Metabolic Therapy at the Crossroad: How to Optimize Myocardial Substrate Utilization?

Aasum, 2002, Cardiac function and metabolism in type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator, Am J Physiol Heart Circ Physiol, 283, H949, 10.1152/ajpheart.00226.2001 Aasum, 2003, Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice, Diabetes, 52, 434, 10.2337/diabetes.52.2.434 Abel, 1999, Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart, J Clin Invest, 104, 1703, 10.1172/JCI7605 Allard, 1997, Glycogen metabolism in the aerobic hypertrophied rat heart, Circulation, 96, 676, 10.1161/01.CIR.96.2.676 Arany, 2005, Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle, Cell Metab, 1, 259, 10.1016/j.cmet.2005.03.002 Arany, 2006, Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha, Proc Natl Acad Sci U S A, 103, 10086, 10.1073/pnas.0603615103 Arikawa, 2007, Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats, Diabetes, 56, 1410, 10.2337/db06-0655 Ashrafian, 2007, Metabolic mechanisms in heart failure, Circulation, 116, 434, 10.1161/CIRCULATIONAHA.107.702795 Augustus, 2006, Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction, J Biol Chem, 281, 8716, 10.1074/jbc.M509890200 Barger, 1999, Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms, Am J Med Sci, 318, 36, 10.1097/00000441-199907000-00006 Barouch, 2003, Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice, Circulation, 108, 754, 10.1161/01.CIR.0000083716.82622.FD Belke, 2000, Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice, Am J Physiol Endocrinol Metab, 279, E1104, 10.1152/ajpendo.2000.279.5.E1104 Bersin, 1997, Dichloroacetate as metabolic therapy for myocardial ischemia and failure, Am Heart J, 134, 841, 10.1016/S0002-8703(97)80007-5 Boudina, 2007, Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins, Diabetes, 56, 2457, 10.2337/db07-0481 Buchanan, 2005, Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity, Endocrinology, 146, 5341, 10.1210/en.2005-0938 Buttrick, 1994, Alterations in gene expression in the rat heart after chronic pathological and physiological loads, J Mol Cell Cardiol, 26, 61, 10.1006/jmcc.1994.1008 Campbell, 2002, A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase, J Biol Chem, 277, 4098, 10.1074/jbc.M106054200 Carley, 2004, Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function, Am J Physiol Endocrinol Metab, 286, E449, 10.1152/ajpendo.00329.2003 Chess, 2009, A high fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload, Am J Physiol Heart Circ Physiol, 297, H1585, 10.1152/ajpheart.00599.2009 D'Alessio, 1994, Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal, J Clin Invest, 93, 2263, 10.1172/JCI117225 Dyck, 2006, Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury, Circulation, 114, 1721, 10.1161/CIRCULATIONAHA.106.642009 Finck, 2002, The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus, J Clin Invest, 109, 121, 10.1172/JCI0214080 Fisher, 1984, Oxygenation and metabolism in the developing heart, Semin Perinatol, 8, 217 Hafstad, 2009, Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss, Cardiovasc Res, 83, 519, 10.1093/cvr/cvp132 Hafstad, 2007, Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice, Am J Physiol Endocrinol Metab, 292, E1288, 10.1152/ajpendo.00504.2006 How, 2005, Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts, Am J Physiol Heart Circ Physiol, 288, H2979, 10.1152/ajpheart.00084.2005 How, 2007, Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice, Arch Physiol Biochem, 113, 211, 10.1080/13813450701783281 Ingwall, 2002 Irie, 2003, Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids, Proc Natl Acad Sci U S A, 100, 6819, 10.1073/pnas.1132094100 Katz, 1995, Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4, Nature, 377, 151, 10.1038/377151a0 Koonen, 2007, CD36 expression contributes to age-induced cardiomyopathy in mice, Circulation, 116, 2139, 10.1161/CIRCULATIONAHA.107.712901 Kuang, 2004, Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia, Circulation, 109, 1550, 10.1161/01.CIR.0000121730.41801.12 Kudo, 1995, High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase, J Biol Chem, 270, 17513, 10.1074/jbc.270.29.17513 Labinskyy, 2007, Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure, J Pharmacol Exp Ther, 321, 165, 10.1124/jpet.106.116871 Lehman, 2000, Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis, J Clin Invest, 106, 847, 10.1172/JCI10268 Liao, 2002, Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice, Circulation, 106, 2125, 10.1161/01.CIR.0000034049.61181.F3 Lionetti, 2005, Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure, Cardiovasc Res, 66, 454, 10.1016/j.cardiores.2005.02.004 Loichot, 2006, Deletion of peroxisome proliferator-activated receptor-alpha induces an alteration of cardiac functions, Am J Physiol Heart Circ Physiol, 291, H161, 10.1152/ajpheart.01065.2004 Lopaschuk, 1994, Regulation of fatty acid oxidation in the mammalian heart in health and disease, Biochim Biophys Acta, 1213, 263, 10.1016/0005-2760(94)00082-4 Luptak, 2005, Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization, Circulation, 112, 2339, 10.1161/CIRCULATIONAHA.105.534594 Luptak, 2007, Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage, J Clin Invest, 117, 1432, 10.1172/JCI30658 Mazumder, 2004, Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts, Diabetes, 53, 2366, 10.2337/diabetes.53.9.2366 McQueen, 2005, Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density, J Mol Cell Cardiol, 39, 882, 10.1016/j.yjmcc.2005.07.017 Morgan, 2006, Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure, Am J Physiol Heart Circ Physiol, 290, H1899, 10.1152/ajpheart.01014.2005 Nahrendorf, 2005, Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction, Cardiovasc Res, 65, 419, 10.1016/j.cardiores.2004.10.006 Neubauer, 2007, The failing heart—an engine out of fuel, N Engl J Med, 356, 1140, 10.1056/NEJMra063052 Nikolaidis, 2004, Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion, Circulation, 109, 962, 10.1161/01.CIR.0000120505.91348.58 O'Donnell, 2008, The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover, J Mol Cell Cardiol, 44, 315, 10.1016/j.yjmcc.2007.11.006 Okere, 2006, Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension, Hypertension, 48, 1116, 10.1161/01.HYP.0000248430.26229.0f Opie, 2004 Poornima, 2008, Chronic glucagon-like peptide-1 (GLP-1) infusion sustains LV systolic function and prolongs survival in the spontaneously hypertensive heart failure prone rat, Circ Heart Fail, 1, 153, 10.1161/CIRCHEARTFAILURE.108.766402 Razeghi, 2001, Metabolic gene expression in fetal and failing human heart, Circulation, 104, 2923, 10.1161/hc4901.100526 Rennison, 2009, Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure, J Mol Cell Cardiol, 46, 883, 10.1016/j.yjmcc.2009.02.019 Rupp, 2000, Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure, Br J Pharmacol, 131, 1748, 10.1038/sj.bjp.0703741 Russell, 2004, Cardiac-specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner, Circ Res, 94, 525, 10.1161/01.RES.0000117088.36577.EB Sambandam, 2006, Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia, Am J Physiol Heart Circ Physiol, 290, H87, 10.1152/ajpheart.00285.2005 Saupe, 1998, Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase, Circ Res, 82, 898, 10.1161/01.RES.82.8.898 Sena, 2009, Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction, J Mol Cell Cardiol, 46, 910, 10.1016/j.yjmcc.2009.02.014 Sharma, 2008, Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat, Am J Physiol Heart Circ Physiol, 294, H1609, 10.1152/ajpheart.00949.2007 Sokos, 2006, Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure, J Card Fail, 12, 694, 10.1016/j.cardfail.2006.08.211 Stenbit, 2000, Preservation of glucose metabolism in hypertrophic GLUT4-null hearts, Am J Physiol Heart Circ Physiol, 279, H313, 10.1152/ajpheart.2000.279.1.H313 Tian, 2003, Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart, Curr Hypertens Rep, 5, 454, 10.1007/s11906-003-0052-7 Tian, 2001, Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis, Circulation, 103, 2961, 10.1161/01.CIR.103.24.2961 Tuunanen, 2006, Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure, Circulation, 114, 2130, 10.1161/CIRCULATIONAHA.106.645184 Vitale, 2004, Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease, Eur Heart J, 25, 1814, 10.1016/j.ehj.2004.06.034 Watanabe, 2000, Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity, J Biol Chem, 275, 22293, 10.1074/jbc.M000248200 Wende, 2009, 3889 Witteles, 2004, Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link, J Am Coll Cardiol, 44, 78, 10.1016/j.jacc.2004.03.037 Yan, 2009, Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity, Circulation, 119, 2818, 10.1161/CIRCULATIONAHA.108.832915 Yang, 2007, CD36 deficiency rescues lipotoxic cardiomyopathy, Circ Res, 100, 1208, 10.1161/01.RES.0000264104.25265.b6 Young, 2001, Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart, J Biol Chem, 276, 44390, 10.1074/jbc.M103826200 Zhao, 2008, Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy, Am J Physiol Heart Circ Physiol, 294, H936, 10.1152/ajpheart.00870.2007